Farther Finance Advisors »

Candel Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $206 20 10.30

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Dimensional International Value Etf Etf (DFIV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Vanguard Value Etf Etf (VTV)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Microsoft Corp Stock (MSFT)
Amazon Stock (AMZN)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)

View all positions for Farther Finance Advisors

Top funds holding Candel Therapeutics

FMR
Rtw Investments
Acorn Capital Advisors
BlackRock
Saturn V Capital Management
Portolan Capital Management
Vanguard Capital Management
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Heights Capital Management
Susquehanna International
Sands Capital Ventures

View all funds holding Candel Therapeutics